Products to launch on Sephora.co.uk
10/05/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230510:nRSJ8579Ya&default-theme=true
RNS Number : 8579Y Cellular Goods PLC 10 May 2023
Press release
10 May 2023
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Products to launch on Sephora.co.uk
Cellular Goods (LSE: CBX), a UK-based skincare and wellness company providing
premium consumer products formulated with lab-produced cannabinoids, is
pleased to announce that it has entered into a contract with multinational
beauty and cosmetics retailer Sephora to make the Company's 'Look Better'
(skincare) range available for purchase on Sephora's e-commerce website,
Sephora.co.uk from the second half of May.
Cellular Goods will become the first cannabigerol (CBG)-based skincare brand
to offer its products on Sephora UK, as part of the Company's enhanced retail
strategy to drive growth by expanding its sales channels and increasing its
collaboration with established online and high street outlets.
Sephora.co.uk will stock the full range of the Company's facial skincare
products including the brand's best-selling Rejuvenating Face Serum, designed
to visibly reverse signs of skin ageing, whilst also protecting from
inflammation and irritation. Cellular Goods' newest range of skincare
products, the Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and
Rejuvenating Day Mousse, containing the Company's proprietary formulation of
CBG and CBD, will also be available on the website.
Additional Cellular Goods products available on Sephora.co.uk include the
Company's CBG-based Nourishing Cannabinoid Face Oil, and Calming Cannabinoid
After Shaving Moisturiser, as well as selected 'mini' sizes and gifting
products during seasonal moments.
Darcy Taylor, Chairman and Interim CEO of Cellular Goods, commented: "I'm
delighted that our products will be going on sale at Sephora.co.uk. The launch
bridges the gap between customer awareness and sales by making it easier for
customers to purchase our products. We're confident that our effective
next-generation skincare formulations will appeal to their existing customers
and encourage them to try our CBG-powered products. The Sephora launch is part
of our continued customer acquisition strategy, as we continue to increase
awareness of our products and grow our sales channels."
For further information please contact:
Cellular Goods
Darcy Taylor via Tancredi +44 207 887 7633
Chairman and interim CEO
Neil Thapar +44 787 645 5323
Investor Relations
First Sentinel Corporate Finance
Corporate Broker & Advisor
Brian Stockbridge +44 7876 888 011
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
Tancredi Intelligent Communication
Media Relations
Helen Humphrey +44 744 922 6720
Charlie Hobbs +44 789 755 7112
cellulargoods@tancredigroup.com (mailto:cellulargoods@tancredigroup.com)
About Cellular Goods PLC:
Cellular Goods develops and markets premium quality skincare and wellness
products based on proprietary formulations incorporating biosynthetic lab-made
cannabinoids. Our branded products are efficacy-led and research-backed and
available online in the UK and US. The Company is incorporated in the UK and
listed on the Main Market of the London Stock Exchange. For more information,
visit www.cellular-goods.com (http://www.cellular-goods.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PRLSSIFAUEDSESI